Russia approves third COVID-19 vaccine,’Kobibag’

Russian Prime Minister Mikhail Mischstein © Reuters = News 1 Source Photo

Russian health authorities have approved a third vaccine for coronavirus infection (Corona 19). After completing the phase 3 clinical procedure, it is planned to begin inoculating 120,000 doses as early as mid-March.

According to Reuters and Russian state RT broadcasting on the 20th, Prime Minister Mikhail Mischstein announced on the same day that “CoviVac, the third corona19 vaccine developed by the Federal Immunology Research and Development Center, has been registered with the Ministry of Health.” did.

The Chumakoff Center was founded in St.

Currently, the first vaccine’Sputnik V’, developed by the Gamalea Research Institute and the Russian Direct Investment Fund (RDIF), is being vaccinated not only in Russia but also in countries around the world, the second vaccine developed by Novosibirsk Vector Virus and Biotechnology Center in October ‘EpiVacCorona’ has been registered.

The two vaccines developed earlier require a three-week interval between the first and second doses, but Kobibag can be vaccinated in two weeks. In addition, there is no fear of infection due to vaccination using inactivated virus bacteria, and distribution and storage are possible at a general refrigeration temperature of 2 to 8 degrees Celsius, the researchers said.

The Russian government plans to start vaccinating Kobibaek’s phase 3 procedure by distributing 120,000 doses in mid-March.

[email protected]

Source